Womb cancer Cancer
Conditions
Interventions
All eligible women will be invited to participate in the trial, with trial information sent to them with their clinic visit appointment letter. Enrolment will be done from the Urgent Suspected Cancer
Sponsors
Sola Diagnostics UK Ltd
Eligibility
Sex/Gender
Female
Age
45 Years to 100 Years
Inclusion criteria
Inclusion criteria: Women with a uterus aged 45 years or more referred for evaluation of abnormal uterine bleeding who are willing and able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Current pregnancy 2. Previous hysterectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome positive and outcome negative participants at 3 months after WID®-easy testing. Outcome positives are defined as cases with histologically confirmed endometrial and/or cervical and/or tubal and/or ovarian cancer. Outcome negatives are defined as cases with (a) histology confirmed absence of any gynaecological cancer and (b) confirmed (imaging and/or histology) absence of gynaecological cancer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome positive and outcome negative participants at 12 months after WID®-easy testing. Outcome positives are defined as cases with histologically confirmed endometrial and/or cervical and/or tubal and/or ovarian cancer. Outcome negatives are defined as cases with (a) histology confirmed absence of any gynaecological cancer and (b) confirmed (imaging and/or histology) absence of gynaecological cancer. | — |
Countries
England, United Kingdom
Outcome results
None listed